About the Cover

RSS

Get Alerts

Processing your request... Please Wait.

You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

In This Issue

Research
Research Notes
Letters
Association Report
Heroes of Pharmacy
Vaccine Update
New Drugs
OTC Products

November-December 2007

| Vol. 47. No. 6

< Previous Issue | Next Issue >

Journal of the American Pharmacists Association

Research

Time from Medicare Part D claim adjudication to community pharmacy payment

Marvin D. Shepherd, PhD; Kristin M. Richards, PhD; Angela L. Winegar; et al.

J Am Pharm Assoc. 2007;47:695-701. doi: 10.1331/JAPhA.2007.07103

Objective To determine the average payment time from Medicare Part D plans to community pharmacies for prescription drugs dispensed to ...

[Continue Reading]

Tags: community pharmacy services, prescription drug, medicare part d

PDF

Pharmacy access to emergency contraception: Perspectives of pharmacists at a chain pharmacy in San Francisco

Shareen Y. El-Ibiary, PharmD, BCPS; Tina Raine, MD, MPH; Jennifer McIntosh, PharmD, MHS; et al.

J Am Pharm Assoc. 2007;47:702-710. doi: 10.1331/JAPhA.2007.06127

Objective To assess pharmacists' perception of their role in dispensing emergency contraception (EC) in San Francisco.

Design Cross-sectional study.

Setting...

[Continue Reading]

Tags: perception, statutes and laws, contraception, postcoital

PDF

Student pharmacist knowledge and attitudes regarding oral emergency contraception

Emily Evans, PharmD; Mallika Patel, PharmD; Derek Stranton; et al.

J Am Pharm Assoc. 2007;47:711-716. doi: 10.1331/JAPhA.2007.06143

Objectives To describe student pharmacist knowledge and attitudes regarding oral emergency contraceptives (OECs) and identify factors affecting student pharmacists' knowledge ...

[Continue Reading]

Tags: attitude, students, pharmacy, contraception, postcoital

PDF

Consumer medication information in the United States, Europe, and Australia: A comparative evaluation

D.K. Theo Raynor, PhD; Bonnie Svarstad, PhD; Peter Knapp, PhD; et al.

J Am Pharm Assoc. 2007;47:717-724. doi: 10.1331/JAPhA.2007.06141

Objective To evaluate the quality of patient information leaflets provided with dispensed medications in the United States, United Kingdom, and ...

[Continue Reading]

Tags: atenolol, medication information

PDF

Evaluation of calcium and vitamin D supplementation in bisphosphonate therapy

Dawn N. Rush, PharmD; Martha W. Jones, PharmD; Debra P. Futrell, PharmD; et al.

J Am Pharm Assoc. 2007;47:725-728. doi: 10.1331/JAPhA.2007.06072

Objective To assess the calcium and vitamin D intake of osteoporosis patients on bisphosphonate therapy.

Design Prospective study.

Setting Two ...

[Continue Reading]

Tags: bisphosphonates, calcium, vitamin d

PDF

Consumer expectations of nonprescription medications according to location of sale

Jeffrey G. Taylor, PhD; Ya-Ning Lo, MSc; Roy Dobson, PhD; et al.

J Am Pharm Assoc. 2007;47:729-736. doi: 10.1331/JAPhA.2007.06140

Objective To determine whether the public has different expectations of nonprescription medications based on location of sale.

Design Cross-sectional, descriptive.

... [Continue Reading]

Tags: drugs, non-prescription

PDF

Factors affecting pharmacists' pediatric asthma counseling

Françoise G. Pradel, MS, PhD; Nour A. Obeidat, MS; Mona G. Tsoukleris, PharmD, BCPS; et al.

J Am Pharm Assoc. 2007;47:737-746. doi: 10.1331/JAPhA.2007.06138

Objective To explore various factors that may influence community pharmacists' pediatric asthma counseling.

Design Cross-sectional.

Setting Maryland from September 2002 ...

[Continue Reading]

Tags: asthma, counseling, asthma, childhood

PDF

Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules

Aleksander P. Winiarski, PharmD; Martin H. Infeld, PhD; Ronald Tscherne, PhD; et al.

J Am Pharm Assoc. 2007;47:747-755. doi: 10.1331/JAPhA.2007.06125

Objectives To develop a simple, standardized method for the extemporaneous compounding of an oral liquid form of oseltamivir from commercially ...

[Continue Reading]

Tags: oseltamivir

PDF

Research Notes

Effects of including medication indications on prescription labels

Nicole L. Burnside, PharmD; Jamie A. Bardo, PharmD; Craig J. Bretz, BPharm, CDE; et al.

J Am Pharm Assoc. 2007;47:756-758. doi: 10.1331/JAPhA.2007.06097

Pharmacists at the Erie Veterans Affairs Medical Center (EVAMC) noticed that many patients did not know why they were using their medications. ... [Continue Reading]

Tags: drug labeling

PDF

Attitudes of Medicare beneficiaries toward pharmacist-provided medication therapy management activities as part of the Medicare Part D benefit

William R. Doucette, PhD; Matthew J. Witry; Fadi Alkhateeb; et al.

J Am Pharm Assoc. 2007;47:758-762. doi: 10.1331/JAPhA.2007.07041

The implementation of Medicare Part D has the potential to improve patient care, lower health care costs, and advance the profession of ... [Continue Reading]

Tags: attitude, counseling, medicare, medication therapy management, medicare part d

PDF

Patient care services in independent community pharmacies: A descriptive report

Gina Peacock, PhD; Robert Kidd, PharmD, MS; Ateequr Rahman, MBA, PhD; et al.

J Am Pharm Assoc. 2007;47:762-764. doi: 10.1331/JAPhA.2007.06124

With the advent of patient-focused care, community pharmacists have become increasingly involved in providing value-added services that go beyond the role of ... [Continue Reading]

Tags: independent community pharmacy

PDF

Letters

Impact of a community pharmacy experience on medical residents' understanding of the role of a community pharmacist

Tricia M. Berry, PharmD, BCPS; Julie A. Murphy, PharmD, BCPS; Audrey K. Montooth, MD; et al.

J Am Pharm Assoc. 2007;47:676-677. doi: 10.1331/JAPhA.2007.07092

Recent Institute of Medicine reports reinforce the importance of an interdisciplinary approach as one strategy to improve safe and appropriate medication use ... [Continue Reading]

Tags: community pharmacy services, medical residencies, community pharmacist

PDF

A call for action: Start a ‘chain reaction’

Sahar Swidan, PharmD; Beatriz Manzor Mitrzyk, PharmD; Kiela Samuels, PharmD; et al.

J Am Pharm Assoc. 2007;47:677-679. doi: 10.1331/JAPhA.2007.07071

Gallup polls have rated pharmacy as one of the most trusted professions for 27 consecutive years. However, the value of pharmacists as ... [Continue Reading]

Tags: insurance, medical coding, medication therapy management

PDF

Association Report

Pharmacists' use of electronic health records: Silent leaders no more

Susan Downard; Kimberly A. Galt, PharmD; Adam Burke Reel; et al.

J Am Pharm Assoc. 2007;47:680-692. doi: 10.1331/JAPhA.2007.07531

Electronic health records (EHRs) offer excellent opportunities for the advancement of patient care by pharmacists and patients themselves. Such records exist in ... [Continue Reading]

Tags: electronic medical records

PDF

Heroes of Pharmacy

Martin Inventius Wilbert 1865–1916: Bridge builder between pharmacy and medicine

Dennis B. Worthen, PhD

J Am Pharm Assoc. 2007;47:768-773. doi: 10.1331/JAPhA.2007.07530

In 1909, The Druggist Circular published a short description of the new secretary of the American Pharmaceutical (now Pharmacists) Association (APhA) Scientific ... [Continue Reading]

Tags: formulary, narcotics, nostrums, trustees, united states public health service, science of chemistry, ...

PDF

Vaccine Update

Vaccines in development: What does the future hold?

Elizabeth A. Sutton; Mary S. Hayney, PharmD, BCPS

J Am Pharm Assoc. 2007;47:775-777. doi: 10.1331/JAPhA.2007.07532

Recent breakthroughs such as the pneumococcal conjugate, human papillomavirus, and zoster vaccines are major contributions to human health. Vaccine research and development ... [Continue Reading]

Tags: vaccines

PDF

New Drugs

New drugs: Maraviroc and lanreotide

Daniel A. Hussar, PhD

J Am Pharm Assoc. 2007;47:778-783. doi: 10.1331/JAPhA.2007.07533

Maraviroc (Selzentry–Pfizer) is the 23rd antiretroviral agent to be marketed in the United States for the treatment of human immunodeficiency virus (HIV) ... [Continue Reading]

Tags: lanreotide, maraviroc

PDF